SynAct Pharma’s Nomination Committee for the 2024 Annual General Meeting was announced in a press release on
The Nomination Committee for the 2024 Annual General Meeting will thereafter consists of the following members:
Niels Ankerstjerne Sloth , Chairman of the Nomination Committee, appointed by Bioinvest Aps- Per Colleen, appointed by
TomEnterprise Public Capital AB - Henrik Stage, appointed by
Goodwind Holding GmbH Anders Kronborg , Chairman of the Board of Directors
The Nomination Committee’s proposed items will be presented in the notice convening the Annual General Meeting and on SynAct’s web site.
© Modular Finance, source